Sanofi Clinical Trials

Clinical trials sponsored by Sanofi — phases, conditions and reported results. Data from ClinicalTrials.gov.

• Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adu
  Phase 1/2 · Respiratory Syncytial Virus Immunization · Completed · Aug 5, 2026
• A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Dis
  Phase 3 · Multiple Sclerosis · Terminated · Jul 12, 2022
• A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Age
  Phase 1/2 · Influenza Immunization · Completed · Aug 4, 2026
• A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus V
  Phase 3 · RSV Immunisation · Terminated · Aug 3, 2026
• Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric o
  Phase 2 · Gastric Cancer · Completed · Jul 30, 2026
• Dupilumab in CRSsNP
  Phase 2 · Chronic Rhinosinusitis Without Nasal Polyps · Completed · Dec 18, 2024
• Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
  Phase 1/2 · HIV Infections · Completed · Feb 18, 2021
• Tuberculosis Clinical Trials Consortium Study 35
  Phase 1/2 · Latent Tuberculosis · Completed · Jul 24, 2026
• TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
  Phase 2 · Pulmonary Tuberculosis · Completed · Jul 23, 2026
• Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial V
  Phase 1 · RSV Infection · Completed · Aug 22, 2025
• Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
  Phase 2 · Atopic Dermatitis · Completed · Jul 13, 2026
• First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or
  Phase 1/2 · Acute Lymphocytic Leukaemia · Terminated · Jul 6, 2026
• Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary
  Phase 3 · Secondary Hyperparathyroidism-Chronic Kidney Disease · Terminated · Jul 2, 2026
• Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
  Phase 2 · Testicular Cancer · Completed · Jul 1, 2026
• Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lu
  Phase 3 · Carcinoma，Non-Small-Cell Lung · Completed · Jun 25, 2026

Trials by company

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

All trials